Results 211 to 220 of about 76,581 (257)

Genomic Structure and Expression Sites of Three Gonadotropin-Releasing Hormone Genes in One Species

, 1998
Richard White, Russell D. Fernald
openalex   +1 more source

Evaluation of the Effect of IL‐1 Antagonists on Pituitary Function

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease frequently observed in populations along the Eastern Mediterranean coast, characterized by recurrent fever, abdominal pain, and joint inflammation. The disease results from mutations in the MEFV gene, which plays a critical role in regulating IL‐1β secretion ...
Fadime Aktas Koc, Baris Sariakcali, Ali Sahin, Vikas Kumar Roy   +3 more
wiley   +1 more source

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
ABSTRACT The hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer subtype accounts for most early and metastatic breast cancer (MBC) cases. HR‐positive/HER2‐negative MBC is characterized by a relatively prolonged, although variable, disease course and substantial intertumoral and intratumoral ...
Akshara Singareeka Raghavendra, Senthil Damodaran, Carlos H. Barcenas, Suzanne A. Fuqua, Rachel M. Layman, Debu Tripathy   +5 more
wiley   +1 more source

Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women. [PDF]

Pharmacol Res Perspect
Brimhall DB, Chen YL, Lee S, Yoshida K, Ufer M.   +4 more
europepmc   +1 more source

NERP‐4–Deleted VGF Impairs β‐Cell Granulogenesis and Insulin Secretion

The FASEB Journal, Volume 39, Issue 24, 31 December 2025.
Neuroendocrine regulatory peptide‐4 (NERP‐4) processed from the VGF promotes insulin secretion and β‐cell maintenance by acting on the amino acid transporter SNAT2. VGF△NERP‐4 impaired β‐cell granulogenesis and granule replenishment needed for the second‐phase insulin secretion.
Weidong Zhang, Yuki Nakazato, Naoto Minamino, Nobuaki Okumura, Ayako Miura, Takefusa Tarusawa, Hiroki Mizukami, Hideyuki Sakoda, Masamitsu Nakazato   +8 more
wiley   +1 more source

Prognostic factors associated with clinical pregnancy in in vitro fertilization using pituitary down-regulation with depot and daily low-dose luteal phase gonadotropin releasing hormone agonists: A single center′s experience

, 2015
Xiaoyan Liang, Caiyun Liao, Rui Huang, RobertaW Scherer   +3 more
openalex   +1 more source

Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use. [PDF]

F S Rep
Enatsu N, Furuhashi K, Otsuki J, Enatsu K, Okamoto E, Kokeguchi S, Shiotani M.   +6 more
europepmc   +1 more source

Glucocorticoid repression of gonadotropin-releasing hormone gene expression and secretion in morphologically distinct subpopulations of GT1-7 cells

, 1997
Barbara Attardi, Toshihiko Tsujii, Robert Friedman, Zhouwen Zeng, James L. Roberts, Tammy Dellovade, Donald W. Pfaff, Uma Chandran, Michael Sullivan, Donald Defranco   +9 more
openalex   +1 more source

A Comparative Study of Quality of Life and Oncologic Outcomes in Premenopausal Women with Hormone Receptor-Positive Breast Cancer: Bilateral Oophorectomy vs. Gonadotropin-Releasing Hormone Agonist Therapy. [PDF]

Cancers (Basel)
Erdemoglu E, Ruddy KJ, Buras MR, Quillen J, Couch FJ, Olson JE, Bozzuto LM, Larson NL, Yi J, Butler KA.   +9 more
europepmc   +1 more source